IL6 and kidney disorder: Given the increased secretion of pro-inflammatory IL-6 observed in MCs treated with LpX in the presence of amiodarone (Fig 7), amiodarone and other drugs that cause phospholipidosis could potentially exacerbate the renal disease associated with FLD.